Country: Kenya

The VCP – Africa CDC study suggests there could be reasons for this reduction other than the disruption of vaccination programmes during the pandemic.

An examination of trends in vaccine confidence across eight sub-Saharan countries between 2020 and 2022.

The VCP-Africa CDC working group has been conducting quantitative research in multiple waves from 2020 to 2022.

An interactive dashboard showcasing data gathered across two waves of quantitative research (Jan-2022 and Aug-2022) conducted as part of the Africa Centres for Disease Control and Prevention Working Group Project.

These reports visualise findings from surveys fielded across 7 African countries in August 2022.

Our third study of COVID-19 vaccine hesitancy among 23,000 respondents in 23 countries, surveyed from 29 June to 10 July 2022 found willingness to accept vaccination at 79.1%, up 5.2% from June 2021.

Vaccine confidence in Kenya is high compared to other countries. The latest data we have for Kenya is from surveys conducted in 2022 which showed that 88% of people feel that vaccines are safe and 84% think they are effective. 84% of those surveyed said they believe it’s important for children to have vaccines and 62% feel that vaccines are compatible with their religious beliefs.

The IRIS Academic Research Group was founded by some of the world’s leading researchers and academic institutions and launched in June 2021 at the inaugural Global Vaccine Confidence Summit as part of the UK government’s G7 Presidency.

Johnson & Johnson Global Public Health has created a series of unbranded research-based tools to equip vaccine confidence efforts in Africa.

This 2-page briefing provides an overview of the key trends and insights observed across the three waves of data collection that have been conducted as part…

Johnson & Johnson Global Public Health has worked with Fraym to create a series of geospatial mapping reports aimed at improving hyper-local understanding of vaccine hesitancy across sub-saharan Africa.

Project to support the development of guidance on interventions to improve vaccine uptake in LMICs, informed by an assessment of local barriers and drivers to adult vaccine uptake.